PortfoliosLab logo
LABD vs. FAZ
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between LABD and FAZ is -0.58. This indicates that the assets' prices tend to move in opposite directions. Negative correlation can be particularly beneficial for diversification and risk management, as one asset may offset the losses of the other during market fluctuations.


-0.50.00.51.0
Correlation: -0.6

Performance

LABD vs. FAZ - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Direxion Daily S&P Biotech Bear 3x Shares (LABD) and Direxion Daily Financial Bear 3X Shares (FAZ). The values are adjusted to include any dividend payments, if applicable.

-99.90%-99.80%-99.70%-99.60%-99.50%NovemberDecember2025FebruaryMarchApril
-99.88%
-99.64%
LABD
FAZ

Key characteristics

Sharpe Ratio

LABD:

-0.12

FAZ:

-0.71

Sortino Ratio

LABD:

0.42

FAZ:

-0.87

Omega Ratio

LABD:

1.05

FAZ:

0.89

Calmar Ratio

LABD:

-0.09

FAZ:

-0.43

Martin Ratio

LABD:

-0.25

FAZ:

-1.24

Ulcer Index

LABD:

37.29%

FAZ:

34.63%

Daily Std Dev

LABD:

81.07%

FAZ:

60.56%

Max Drawdown

LABD:

-99.97%

FAZ:

-100.00%

Current Drawdown

LABD:

-99.95%

FAZ:

-100.00%

Returns By Period

In the year-to-date period, LABD achieves a 20.91% return, which is significantly higher than FAZ's -8.21% return.


LABD

YTD

20.91%

1M

5.58%

6M

45.11%

1Y

-17.25%

5Y*

-40.20%

10Y*

N/A

FAZ

YTD

-8.21%

1M

4.55%

6M

-19.38%

1Y

-43.96%

5Y*

-51.11%

10Y*

-43.48%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


LABD vs. FAZ - Expense Ratio Comparison

LABD has a 1.06% expense ratio, which is lower than FAZ's 1.07% expense ratio.


Expense ratio chart for FAZ: current value is 1.07%, compared with the broader market range of 0.00% to 2.12%.0.50%1.00%1.50%2.00%
FAZ: 1.07%
Expense ratio chart for LABD: current value is 1.06%, compared with the broader market range of 0.00% to 2.12%.0.50%1.00%1.50%2.00%
LABD: 1.06%

Risk-Adjusted Performance

LABD vs. FAZ — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

LABD
The Risk-Adjusted Performance Rank of LABD is 2121
Overall Rank
The Sharpe Ratio Rank of LABD is 1414
Sharpe Ratio Rank
The Sortino Ratio Rank of LABD is 3434
Sortino Ratio Rank
The Omega Ratio Rank of LABD is 2929
Omega Ratio Rank
The Calmar Ratio Rank of LABD is 1313
Calmar Ratio Rank
The Martin Ratio Rank of LABD is 1515
Martin Ratio Rank

FAZ
The Risk-Adjusted Performance Rank of FAZ is 22
Overall Rank
The Sharpe Ratio Rank of FAZ is 22
Sharpe Ratio Rank
The Sortino Ratio Rank of FAZ is 22
Sortino Ratio Rank
The Omega Ratio Rank of FAZ is 22
Omega Ratio Rank
The Calmar Ratio Rank of FAZ is 33
Calmar Ratio Rank
The Martin Ratio Rank of FAZ is 33
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

LABD vs. FAZ - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Direxion Daily S&P Biotech Bear 3x Shares (LABD) and Direxion Daily Financial Bear 3X Shares (FAZ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The chart of Sharpe ratio for LABD, currently valued at -0.12, compared to the broader market-1.000.001.002.003.004.00
LABD: -0.12
FAZ: -0.71
The chart of Sortino ratio for LABD, currently valued at 0.42, compared to the broader market-2.000.002.004.006.008.00
LABD: 0.42
FAZ: -0.87
The chart of Omega ratio for LABD, currently valued at 1.05, compared to the broader market0.501.001.502.002.50
LABD: 1.05
FAZ: 0.89
The chart of Calmar ratio for LABD, currently valued at -0.09, compared to the broader market0.002.004.006.008.0010.0012.00
LABD: -0.09
FAZ: -0.43
The chart of Martin ratio for LABD, currently valued at -0.25, compared to the broader market0.0020.0040.0060.00
LABD: -0.25
FAZ: -1.24

The current LABD Sharpe Ratio is -0.12, which is higher than the FAZ Sharpe Ratio of -0.71. The chart below compares the historical Sharpe Ratios of LABD and FAZ, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-2.00-1.50-1.00-0.500.000.501.00NovemberDecember2025FebruaryMarchApril
-0.12
-0.71
LABD
FAZ

Dividends

LABD vs. FAZ - Dividend Comparison

LABD's dividend yield for the trailing twelve months is around 3.77%, less than FAZ's 6.83% yield.


TTM2024202320222021202020192018
LABD
Direxion Daily S&P Biotech Bear 3x Shares
3.77%4.68%6.14%0.53%0.00%3.96%1.75%0.80%
FAZ
Direxion Daily Financial Bear 3X Shares
6.83%7.36%4.88%0.00%0.00%0.62%1.62%0.57%

Drawdowns

LABD vs. FAZ - Drawdown Comparison

The maximum LABD drawdown since its inception was -99.97%, roughly equal to the maximum FAZ drawdown of -100.00%. Use the drawdown chart below to compare losses from any high point for LABD and FAZ. For additional features, visit the drawdowns tool.


-100.00%-99.95%-99.90%-99.85%-99.80%-99.75%-99.70%-99.65%NovemberDecember2025FebruaryMarchApril
-99.95%
-99.76%
LABD
FAZ

Volatility

LABD vs. FAZ - Volatility Comparison

Direxion Daily S&P Biotech Bear 3x Shares (LABD) has a higher volatility of 45.61% compared to Direxion Daily Financial Bear 3X Shares (FAZ) at 41.43%. This indicates that LABD's price experiences larger fluctuations and is considered to be riskier than FAZ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%20.00%30.00%40.00%50.00%NovemberDecember2025FebruaryMarchApril
45.61%
41.43%
LABD
FAZ